We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.35B
AUM Growth
+$162M
Cap. Flow
+$9.89M
Cap. Flow %
0.42%
Top 10 Hldgs %
51.28%
Holding
86
New
9
Increased
45
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$49.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$40.7M
3
INCY icon
Incyte
INCY
+$26.8M
4
PTCT icon
PTC Therapeutics
PTCT
+$26.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$21.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$96M
2
PFE icon
Pfizer
PFE
+$53.7M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$46.4M
4
AGN
Allergan plc
AGN
+$36.3M
5
RLYP
RELYPSA INC COM
RLYP
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 97.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
76
Pacira BioSciences
PCRX
$1.04B
– –
-18,357
Closed -$754K
PFE icon
77
Pfizer
PFE
$143B
– –
-1,803,411
Closed -$53.7M
LCI
78
DELISTED
Lannett Company, Inc.
LCI
– –
-8,448
Closed -$1.4M
TTPH
79
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-34,602
Closed -$5.16M
PTLA
80
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-1,088,118
Closed -$46.4M
HZNP
81
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-67,852
Closed -$1.34M
RLYP
82
DELISTED
RELYPSA INC COM
RLYP
– –
-842,030
Closed -$15.6M
ZSPH
83
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-42,000
Closed -$2.76M
OMED
84
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-109,211
Closed -$1.81M
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sectoral Asset Management held 86 positions worth $2.35B, up 7.4% from $2.18B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sectoral Asset Management's Q4 2015 filing shows 9 new, 45 increased, 20 reduced and 11 closed positions. Its largest new stake was Eli Lilly: 599,245 shares worth $50.5M. The largest sale was Biogen, an estimated $96M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier.

  • Sectoral Asset Management's largest Q4 2015 buy was Eli Lilly: 599,245 shares worth $50.5M.
  • Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q4 2015, an estimated $40.7M increase.
  • Sectoral Asset Management's biggest Q4 2015 reduction was Biogen, cutting an estimated $96M.
  • Sectoral Asset Management fully exited Pfizer in Q4 2015, selling an estimated $53.7M.
  • Sectoral Asset Management's ten largest holdings make up 51% of its $2.35B portfolio in Q4 2015.
  • Sectoral Asset Management opened 9 new positions and closed 11 in Q4 2015.
  • Sectoral Asset Management's portfolio value rose 7.4% quarter-over-quarter to $2.35B.

Based on Sectoral Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.